These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35069904)

  • 1. Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer.
    Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
    J Cancer; 2022; 13(2):579-588. PubMed ID: 35069904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery.
    Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
    Bioengineered; 2021 Dec; 12(2):12383-12393. PubMed ID: 34895063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.
    Rybakova Y; Kowalski PS; Huang Y; Gonzalez JT; Heartlein MW; DeRosa F; Delcassian D; Anderson DG
    Mol Ther; 2019 Aug; 27(8):1415-1423. PubMed ID: 31160223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses.
    Shuptrine CW; Chen Y; Miriyala J; Lenz K; Moffett D; Nguyen TA; Michaux J; Campbell K; Smith C; Morra M; Rivera-Molina Y; Murr N; Cooper S; McGuire A; Makani V; Oien N; Zugates JT; de Silva S; Schreiber TH; de Picciotto S; Fromm G
    Cancer Res; 2024 May; 84(10):1550-1559. PubMed ID: 38381555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.
    Vlatkovic I
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of VEGFA mRNA for promoting wound healing via ionizable lipid nanoparticles.
    Dong S; Wang J; Guo Z; Zhang Y; Zha W; Wang Y; Liu C; Xing H; Li X
    Bioorg Med Chem; 2023 Jan; 78():117135. PubMed ID: 36577327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters.
    Deng YQ; Zhang NN; Zhang YF; Zhong X; Xu S; Qiu HY; Wang TC; Zhao H; Zhou C; Zu SL; Chen Q; Cao TS; Ye Q; Chi H; Duan XH; Lin DD; Zhang XJ; Xie LZ; Gao YW; Ying B; Qin CF
    Cell Res; 2022 Apr; 32(4):375-382. PubMed ID: 35210606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.
    Hsu FF; Liang KH; Kumari M; Chen WY; Lin HT; Cheng CM; Tao MH; Wu HC
    Int J Pharm; 2022 Nov; 627():122256. PubMed ID: 36198358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection.
    Erasmus JH; Archer J; Fuerte-Stone J; Khandhar AP; Voigt E; Granger B; Bombardi RG; Govero J; Tan Q; Durnell LA; Coler RN; Diamond MS; Crowe JE; Reed SG; Thackray LB; Carnahan RH; Van Hoeven N
    Mol Ther Methods Clin Dev; 2020 Sep; 18():402-414. PubMed ID: 32695842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
    Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
    Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
    Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
    Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of VEGF-A mRNA for promoting diabetic wound healing via ionizable lipid nanoparticles.
    Zha W; Wang J; Guo Z; Zhang Y; Wang Y; Dong S; Liu C; Xing H; Li X
    Int J Pharm; 2023 Feb; 632():122565. PubMed ID: 36586634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
    Tanaka H; Hagiwara S; Shirane D; Yamakawa T; Sato Y; Matsumoto C; Ishizaki K; Hishinuma M; Chida K; Sasaki K; Yonemochi E; Ueda K; Higashi K; Moribe K; Tadokoro T; Maenaka K; Taneichi S; Nakai Y; Tange K; Sakurai Y; Akita H
    ACS Nano; 2023 Feb; 17(3):2588-2601. PubMed ID: 36719091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage
    Duperret EK; Trautz A; Stoltz R; Patel A; Wise MC; Perales-Puchalt A; Smith T; Broderick KE; Masteller E; Kim JJ; Humeau L; Muthumani K; Weiner DB
    Cancer Res; 2018 Nov; 78(22):6363-6370. PubMed ID: 30287678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles.
    Chen CY; Tran DM; Cavedon A; Cai X; Rajendran R; Lyle MJ; Martini PGV; Miao CH
    Mol Ther Nucleic Acids; 2020 Jun; 20():534-544. PubMed ID: 32330871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
    El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
    J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.